Chronic-phase chronic myeloid leukemia: Incidence of BCR/ABL transcript and its correlation with presenting features, response to treatment, and survival.

Laabidi, Baraa; Slama, Nader; Ouahchi, Ines; Boufrikha, Wiem; Laatiri, Mohamed Adnene

Laabidi, Baraa; Slama, Nader; Ouahchi, Ines; Boufrikha, Wiem; Laatiri, Mohamed Adnene.

Afiliación

Laabidi B; Hematology Department, Fattouma Bourguiba University Hospital, Monastir, Tunisia.
Slama N; Hematology Department, Fattouma Bourguiba University Hospital, Monastir, Tunisia.
Ouahchi I; Cytogenetics, Molecular Genetics and Reproductive Biology Department, Farhat Hached University Hospital, Sousse, Tunisia.
Boufrikha W; Hematology Department, Fattouma Bourguiba University Hospital, Monastir, Tunisia.
Laatiri MA; Hematology Department, Fattouma Bourguiba University Hospital, Monastir, Tunisia.

Leuk Res Rep ; 20: 100373, 2023.

Article en En | MEDLINE | ID: mdl-37521582

Palabras clave

BCR-ABL transcript; Chronic phase; Imatinib mesylate; Myeloproliferative disorder; Philadelphia chromosome

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Año: 2023 Tipo del documento: Article